Blue Wave Compounds has announced the availability of GLP2-T (BW2-T), a synthetic tirzepatide in seven vial sizes.
-- Blue Wave Compounds has announced the availability of a research-use-only GLP2-T (BW2-T), a synthetic tirzepatide now offered by the company in seven vial sizes ranging from 5 mg to 120 mg. Designed for scientific researchers investigating metabolic regulation, glucose homeostasis, appetite suppression, and body weight management, this compound meets industry-standard analytical specifications, with purity confirmed at ≥99% by high-performance liquid chromatography (HPLC) and molecular identity verified via electrospray ionization mass spectrometry (ESI-MS) at approximately 4813.52 Da.
More information is available at https://bluewavecompounds.com/product/glp-t
This availability addresses a need in metabolic research, where dual-mechanism compounds enable investigators to study complex physiological pathways that single-agonist peptides cannot fully replicate. Tirzepatide's dual action on both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors positions researchers to study integrated metabolic responses that more closely model the multifactorial nature of obesity, type 2 diabetes, and related disorders.
The new product is a synthetic 39-amino-acid peptide engineered to activate both GIP and GLP-1 receptors, mechanisms that work in concert to regulate glucose metabolism and energy balance. In laboratory and preclinical models, this dual agonist has demonstrated effects on glucose homeostasis by enhancing glucose-dependent insulin secretion while suppressing glucagon release, slowing gastric emptying to modulate nutrient absorption, and reducing food intake through central appetite pathways.
As indicated by the 'Research Use Only' designation, the product is strictly for scientific investigation in laboratory settings, including in vitro studies, animal testing, and preclinical research, and is not evaluated or approved by the U.S. Food and Drug Administration for human or animal consumption, diagnosis, or treatment.
GLP2-T is available in seven vial sizes-5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 60 mg, and 120 mg-supplied as lyophilized powder in 3 mL vials, with pricing ranging from $40 to $285 depending on vial size. All products require reconstitution with an appropriate diluent prior to use. Batch-specific Certificates of Analysis (COAs) from independent third-party laboratories are available for each product sold.
Blue Wave Compounds operates as a research-grade peptide supplier that prioritizes quality, transparency, and researcher success through advanced synthesis methods and adherence to production standards informed by cGMP principles. Researchers can access detailed COAs, product specifications, and ordering information through the company website.
For additional details, visit https://bluewavecompounds.com/
Contact Info:
Name: Tina Lipkin
Email: Send Email
Organization: Blue Wave Compounds
Address: 3948 3 RD Street South 58, Jacksonville Beach, Florida 32250, United States
Phone: +1-833-457-7377
Website: https://bluewavecompounds.com/
Source: PressCable
Release ID: 89201757
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
